|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Investment in Cuqqenheim Credit Income Fund (“GCIF”) 17,061,497 shares purchased at a cost of $17,330 and 17,061,497 shares purchased at a cost of $17,330, respectively) | |||||||||
| Cash | |||||||||
| Total assets | |||||||||
| Liabilities | |||||||||
| Accounts payable, accrued expenses and other liabilities | |||||||||
| Accrued professional services fees | |||||||||
| Payable to related parties | |||||||||
| Total liabilities | |||||||||
| Net Assets | |||||||||
| Net asset value per Common Share (NAV) | |||||||||
| Components of Net Assets: | |||||||||
| Common Shares, $0.001 par value, 1,000,000,000 Common Shares authorized, 16,297,188 and 16,297,188 Common Shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | |||||||||
| Paid-in-capital in excess of par value | |||||||||
| Accumulated loss, net of distributions |
Loading...
